Market Place
Sourcing Support
EU authorities revoke marketing nod for Advanz Pharma`s Ocaliva
03 Dec 2024 //
FIERCE PHARMA
Advanz Pharma Responds to Reversal of Suspension on Ocaliva®
27 Nov 2024 //
GLOBENEWSWIRE
EMA Accepts Marketing Application for AVT05 Biosimilar to Simponi®
04 Nov 2024 //
GLOBENEWSWIRE
Advanz Pharma Secures Suspension Of EC Decision On OCALIVA
05 Sep 2024 //
GLOBENEWSWIRE
Advanz Pharma Responds to EU Commission`s OCALIVA Revocation for PBC
03 Sep 2024 //
GLOBENEWSWIRE
Alvotech & Advanz announce commercialisation agreement for Eylea biosimilar
18 Jun 2024 //
PHARMAFILE
UK MHRA approves Advanz Pharma antibiotic for complex infections
05 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
ADVANZ PHARMA and Veeva Systems link for digital operations in Europe
22 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
ADVANZ PHARMA Partners with Veeva to Set Unified Digital-First Foundation
20 Jun 2023 //
PR NEWSWIRE
Advanz strengthens its pharma portfolio by acquiring Tostran from Kyowa Kirin
25 Apr 2023 //
PRESS RELEASE
Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Xolair
06 Feb 2023 //
GLOBENEWSWIRE
In appeal, Advanz calls UK fine `manifestly wrong`
27 Sep 2022 //
FIERCEPHARMA
Intercept Announces Closing of Transaction with Advanz Pharma on Ocaliva
01 Jul 2022 //
GLOBENEWSWIRE
Intercept Announces Advanz Pharma to Acquire Ocaliva in PBC
05 May 2022 //
GLOBENEWSWIRE
Allecra, ADVANZ PHARMA Sign Exclusive Agreement for Cefepime/enmetazobactam
12 Jan 2022 //
BIOSPACE
ADVANZ PHARMA makes key changes to senior leadership
18 Nov 2021 //
PRNEWSWIRE
Class 3 Medicines Recall: Advanz Pharma, Carbimazole 10mg and 15mg tablets
20 May 2021 //
GOV.UK
ADVANZ and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba®
13 Apr 2021 //
GLOBNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.